a public good project by the
Synthesis
Company
of California

© 2026

Mark E. Gurney | doi.page

0 works0 citations0 h-index

Mark E. Gurney

Mayo Clinic(US)Mayo Clinic in Arizona(US)

Publications by Year

Research Areas

Amyotrophic Lateral Sclerosis Research, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Neurological diseases and metabolism, Immune Cell Function and Interaction

Most-Cited Works

→ Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation(1994)4,111 cited
→ Neuregulin 1 and Susceptibility to Schizophrenia(2002)1,659 cited
→ Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity(1999)1,430 cited
→ The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke(2004)925 cited
→ aph-1 and pen-2 Are Required for Notch Pathway Signaling, γ-Secretase Cleavage of βAPP, and Presenilin Protein Accumulation(2002)795 cited
→ Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis(2000)598 cited

→ Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS(1998)

494 cited

→ Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)(1995)429 cited

→ Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.(1996)411 cited

Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis.(1994)